MasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
MasterPharm LLC is recalling Progesterone 300 mg Troches because the product lacks assurance of conformity to specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The specific reason is a lack of processing controls, which is a quality assurance issue rather than a confirmed contamination or defect causing immediate harm.
Plain-English summary
MasterPharm LLC is recalling Progesterone 300 mg Troches, 30 troches per bottle, due to a lack of processing controls. The recall is initiated because there is a lack of assurance that the product conforms to specifications.
The affected product is identified by the code 02-05-2020:86@14 and has a best-use date of August 3, 2020. The recall covers 90 troches distributed nationwide in the United States.
Consumers who have this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for further instructions.
The recalled product
- Product
- Progesterone 300 mg Troche, 30 troches per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Pharmaceutical
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 02-05-2020:86@14
- BUD 8/3/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Same hazard · lack of processing controls
See all →- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Minoxidil/Biotin/Spironolactone Capsules Due to Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Yohimbine HCL Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05